Veradermics, looking to tousle the pattern hair loss market, locks down $150M series C

15th October 2025 Uncategorised 0

Veradermics will use the funding to support further phase 3 development for its extended-release formulation of oral minoxidil, a decades-old hypertension treatment that’s commonly used off-label for hair loss.

More: Veradermics, looking to tousle the pattern hair loss market, locks down 0M series C
Source: fierce